$KTOV remember when management had a line in their reasoning for needing to raise cash due to potential M/A with other smaller biotechs... i think the wording was potential strategic acquisitions... it seems as if they were referring to an M/A with tyrnovo the whole time. Makes Lilly’s buyout a shitload easier.
  • 16